February 22, 2018 / 6:51 AM / 3 months ago

BRIEF-Neovacs Obtains U.S. Patent For Treatment Of Interpheron Alpha Related Conditions​

Feb 22 (Reuters) - NEOVACS SA:

* ‍HAS BEEN GRANTED BY UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) A PATENT ​

* ‍PATENT ENTITLED “METHOD FOR TREATING INTERPHERON ALPHA RELATED CONDITIONS”​

* ‍ASSURES IN THIS COUNTRY PROTECTION OF ITS TECHNOLOGY PLATFORM AT LEAST UNTIL 2032​

* ‍RESULTS OF PHASE IIB TRIAL IN LUPUS WITH THE IFN KINOID SHOULD BE COMMUNICATED BY JUNE THIS YEAR​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below